TechNOW podcast: Breathable treatment for drug-resistant TB

Published: Oct. 29, 2021, 6:22 a.m.

COVID isn\u2019t the only pandemic threat we face. The infectious disease that killed the most people in 2018 wasn\u2019t malaria or HIV: it was tuberculosis.\n\nBecause of antibiotic resistance, a growing number of TB infections can\u2019t be cured by current methods. Rising fever, chest-pain, coughing up blood \u2013 without new treatments, this ancient sickness could become a future crisis.\n\nBut what if we could treat antibiotic resistant TB with a new drug delivered straight into the lungs by an asthma-puffer style device? \n\nThanks to new technology developed by Associate Professor Charlotte Conn, her team at RMIT, and their collaborators in India, this dream cure could become a reality.\n\nTechNOW is a podcast about Australian innovations that are shaping the future, thanks to the Global Connections fund \u2013 a project run by the Australian Academy of Technology and Engineering and supported by the Australian Government.